Methods of inhibiting vascular permeability and apoptosis

Details for Australian Patent Application No. 2004253473 (hide)

Owner University of Connecticut

Inventors Claffey, Kevin P.; Hla, Timothy; Paik, JiHye; Sanchez, Teresa

Agent Fisher Adams Kelly

Pub. Number AU-B-2004253473

PCT Pub. Number WO2005/002559

Priority 60/482,234 24.06.03 US

Filing date 18 June 2004

Wipo publication date 13 January 2005

Acceptance publication date 4 March 2010

International Classifications

A61K 31/00 (2006.01)

A61K 31/133 (2006.01) - having hydroxy groups, e.g. sphingosine

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

12 January 2006 PCT application entered the National Phase

  PCT publication WO2005/002559 Priority application(s): WO2005/002559

4 March 2010 Application Accepted

  Published as AU-B-2004253473

1 July 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004253474-Conjugated complement cascade inhibitors

2004253471-Delivery of therapeutic compounds to the brain and other tissues